CVS Health Corp. CVS reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday. Adjusted ...

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health Corporation (NYSE:CVS) reported fourth-quarter results that came in ahead of market expectations, though the ...

Some payments that were originally expected in early 2026 instead arrived late in 2025, boosting reported 2025 cash flow but reducing 2026’s starting point. As a result, CVS now guides to at least $9 ...

CVS Health Corporation (NYSE:CVS) is one of the stocks in focus on Jim Cramer’s game plan. Cramer highlighted the stock’s ...

--CVS Health Corporation today announced operating results for the three months ended March 31, 2025. For the three months ended March 31, 2025 compared to the prior year:. See pages 3 through 6 for ...

CVS Health Corporation (NYSE:CVS) is one of the best affordable healthcare stocks to buy now. CVS Health Corporation (NYSE:CVS) received a rating update from RBC Capital on December 18, with the firm ...

CVS Health Corp. (NYSE:CVS), and Humana Inc. (NYSE:HUM) declined last week, but while investors focused on the Donald Trump administration’s proposed near-zero increase in Medicare Advantage, another ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The job cuts are part of a plan ...

CVS Health Corporation (NYSE:CVS) is one of the best healthcare stocks to buy for 2026. On January 27, BofA Securities cut its price target on CVS Health (NYSE: CVS) to $95 from $100 while keeping a ...

Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior year GAAP diluted EPS of $2.30 and Adjusted EPS of $1.09 Full-Year Highlights Total revenues ...